Back
Neurogene, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
NGNE
Neurogene, Inc.
Last Price:
$20.54
Seasonality Move:
13.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurogene, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.21 | Buy |
| 20-day SMA: | 20.33 | Buy |
| 50-day SMA: | 25.68 | Sell |
| 200-day SMA: | 19.87 | Buy |
| 8-day EMA: | 20.06 | Buy |
| 20-day EMA: | 21.01 | Sell |
| 50-day EMA: | 22.73 | Sell |
| 200-day EMA: | 22.61 | Sell |
Neurogene, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.28 | Sell |
| Relative Strength Index (14 RSI): | 44.96 | Sell |
| Chaikin Money Flow: | 266492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.72 - 21.44) | Sell |
| Bollinger Bands (100): | (17.76 - 27.9) | Sell |
Neurogene, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurogene, Inc. Stock
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 20.55 while NGNE 8-day simple moving average is 20.21, which is a Buy signal.
-
The stock price of NGNE is 20.55 while Neurogene, Inc. 20-day SMA is 20.33, which makes it a Buy.
-
Neurogene, Inc. 50-day simple moving average is 25.68 while NGNE share price is 20.55, making it a Sell technically.
-
NGNE stock price is 20.55 and Neurogene, Inc. 200-day simple moving average is 19.87, creating a Buy signal.
NGNE Technical Analysis vs Fundamental Analysis
Sell
46
Neurogene, Inc. (NGNE)
is a Sell
Is Neurogene, Inc. a Buy or a Sell?
-
Neurogene, Inc. stock is rated a SellThe current Neurogene, Inc. [NGNE] share price is $20.55. The Score for NGNE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Neurogene, Inc. Stock Info
Market Cap:
318.3M
Price in USD:
20.55
Share Volume:
402.8K
Neurogene, Inc. 52-Week Range
52-Week High:
37.27
52-Week Low:
6.88
Sell
46
Neurogene, Inc. (NGNE)
is a Sell
Neurogene, Inc. Share Price Forecast
-
What is the Neurogene, Inc. stock price today?The Neurogene, Inc. stock price is 20.55 USD today.
-
Will NGNE stock go up or go down?Neurogene, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurogene, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurogene, Inc. is overvalued.
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 20.55 while NGNE 8-day exponential moving average is 20.06, which is a Buy signal.
-
The stock price of NGNE is 20.55 while Neurogene, Inc. 20-day EMA is 21.01, which makes it a Sell.
-
Neurogene, Inc. 50-day exponential moving average is 22.73 while NGNE share price is 20.55, making it a Sell technically.
-
NGNE stock price is 20.55 and Neurogene, Inc. 200-day simple moving average is 22.61, creating a Sell signal.
Fundamental Analysis of Neurogene, Inc.
Is Neurogene, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Neurogene, Inc.
Should I short Neurogene, Inc. stock?
-
NGNE Moving Average Covergence Divergence (MACD) indicator is -1.28, suggesting Neurogene, Inc. is a Sell
-
Neurogene, Inc. Relative Strength Index (RSI) is 44.96, which suggest Neurogene, Inc. is oversold
-
The Bollinger Bands (25) for Neurogene, Inc. is (19.72 - 21.44), which suggest Neurogene, Inc. is a Sell
-
The Bollinger Bands (100) for Neurogene, Inc. is (17.76 - 27.9), which suggest Neurogene, Inc. is a Sell
* Neurogene, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.